Cargando…

Visceral fat and attribute-based medicine in chronic kidney disease

Visceral adipose tissue plays a central role in obesity and metabolic syndrome and is an independent risk factor for both cardiovascular and metabolic disorders. Increased visceral adipose tissue promotes adipokine dysregulation and insulin resistance, leading to several health issues, including sys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kataoka, Hiroshi, Nitta, Kosaku, Hoshino, Junichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947142/ https://www.ncbi.nlm.nih.gov/pubmed/36843595 http://dx.doi.org/10.3389/fendo.2023.1097596

Ejemplares similares

Glomerular hyperfiltration and hypertrophy: an evaluation of maximum values in pathological indicators to discriminate “diseased” from “normal”
por: Kataoka, Hiroshi, et al.
Publicado: (2023)

Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Association between metabolic scores for visceral fat and chronic kidney disease: A cross-sectional study
por: Yu, Peng, et al.
Publicado: (2022)

Impacts of Sex Differences in Pulse Pressure among Patients with Chronic Kidney Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Diabetic kidney disease progression is associated with decreased lower-limb muscle mass and increased visceral fat area in T2DM patients
por: Lin, Xiaopu, et al.
Publicado: (2022)

Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2022)

Visceral fat correlates with insulin secretion and sensitivity independent of BMI and subcutaneous fat in Chinese with type 2 diabetes
por: Huang, Haishan, et al.
Publicado: (2023)

Possible Link between Metabolic Syndrome and Chronic Kidney Disease in the Development of Cardiovascular Disease
por: Nitta, Kosaku
Publicado: (2010)

Management of Osteoporosis in Chronic Kidney Disease
por: Nitta, Kosaku, et al.
Publicado: (2017)

Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients
por: Ran, Zijing, et al.
Publicado: (2021)

Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease
por: Nitta, Kosaku
Publicado: (2010)

Renal fat fraction is significantly associated with the risk of chronic kidney disease in patients with type 2 diabetes
por: Shen, Yan, et al.
Publicado: (2022)

Is the visceral adiposity index a potential indicator for the risk of kidney stones?
por: Hou, Bingbing, et al.
Publicado: (2022)

Interaction Among Sex, Aging, and Epigenetic Processes Concerning Visceral Fat, Insulin Resistance, and Dyslipidaemia
por: Arpón, Ana, et al.
Publicado: (2019)

Asthma prevalence is increased in patients with high metabolism scores for visceral fat: study reports from the US
por: Liu, Qiushi, et al.
Publicado: (2023)

Plasma IGFBP-2 levels reveal heterogeneity in hepatic fat content in adults with excess visceral adiposity
por: Rauzier, Chloé, et al.
Publicado: (2023)

Towards visceral fat estimation at population scale: correlation of visceral adipose tissue assessment using three-dimensional cross-sectional imaging with BIA, DXA, and single-slice CT
por: Chan, Benjamin, et al.
Publicado: (2023)

The Role of Fat Reducing Agents on Adipocyte Death and Adipose Tissue Inflammation
por: Muskat, Ahava, et al.
Publicado: (2022)

A Reliable Estimate of Visceral Fat Area From Simple Anthropometric Measurements in Chinese Overweight and Obese Individuals
por: Liu, Hanying, et al.
Publicado: (2022)

Excess visceral fat area as an independent risk factor for early postoperative complications in patients with obesity undergoing bariatric surgery
por: Han, Liping, et al.
Publicado: (2023)

Anticipated correlation between lean body mass to visceral fat mass ratio and insulin resistance: NHANES 2011-2018
por: Shao, Ya, et al.
Publicado: (2023)

Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study
por: Kataoka, Hiroshi, et al.
Publicado: (2022)

Assessing the usefulness of a newly proposed metabolic score for visceral fat in predicting future diabetes: results from the NAGALA cohort study
por: Yang, Ruijuan, et al.
Publicado: (2023)

Trends of national and sub-national burden attributed to kidney dysfunction risk factor in Iran: 1990-2019
por: Nejadghaderi, Seyed Aria, et al.
Publicado: (2023)

Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?
por: Martin, William P., et al.
Publicado: (2020)

Association of adiposity with hemoglobin levels in patients with chronic kidney disease not on dialysis
por: Honda, Hirokazu, et al.
Publicado: (2017)

Crosstalk between bone and muscle in chronic kidney disease
por: Wong, Limy, et al.
Publicado: (2023)

Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload
por: Suzuki, Shunji, et al.
Publicado: (2018)

Correction to: Association of adiposity with hemoglobin levels in patients with chronic kidney disease not on dialysis
por: Honda, Hirokazu, et al.
Publicado: (2018)

Associations of endogenous androgens and sex hormone-binding globulin with kidney function and chronic kidney disease
por: Lau, Lina Hui Ying, et al.
Publicado: (2022)

3,5-Diiodo-L-Thyronine (T2) Administration Affects Visceral Adipose Tissue Inflammatory State in Rats Receiving Long-Lasting High-Fat Diet
por: Petito, Giuseppe, et al.
Publicado: (2021)

Joint association of hyperuricemia and chronic kidney disease with mortality in patients with chronic heart failure
por: Wang, Chi, et al.
Publicado: (2023)

The association of apolipoprotein B with chronic kidney disease in the Chinese population
por: Xu, Yu, et al.
Publicado: (2023)

Recent advances in the treatment of patients with obesity and chronic kidney disease
por: Abdul Wahab, Roshaida, et al.
Publicado: (2023)

Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Required Surgical Treatment
por: Watanabe, Kentaro, et al.
Publicado: (2018)

Visceral adiposity measures are strongly associated with cardiovascular disease among female participants in Southwest China: A population-based prospective study
por: Wang, Yingying, et al.
Publicado: (2022)

Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity
por: Cunha, Guilherme Moura, et al.
Publicado: (2020)

Hypothyroidism: The difficulty in attributing symptoms to their underlying cause
por: Jansen, Heleen I., et al.
Publicado: (2023)

Low glomerular number at birth can lead to the development of chronic kidney disease
por: Fukunaga, Shohei, et al.
Publicado: (2023)

Chemerin levels in chronic kidney disease: A systematic review and meta-analysis
por: Behnoush, Amir Hossein, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6lnb5dgar3ldhr4veu5k87enji